ARCHIVES

NCI Evaluating PDQ Evaluation

This article is from The Cancer Letter archive.

Vol. 15 No. 35 | September 1, 1989

Download PDF Visit The Full Archive

Related Articles

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

July 4, 1997

RFP: Intellectual Property.

March 31, 2000

In Brief: NCI’s Katz Named Director, Arthritis Institute; Hayden Promoted At Bristol-Myers Squibb

July 14, 1995

Report Finds NIH Not At Fault in Case Of P-32 Ingestion

September 26, 1997

ACCC Presentations On Care In Community

March 27, 1981

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

November 26, 2010